We have recently shown that two proteins, proliferating cell nuclear antigen (PCNA) and p21, are associated with cyclin D. Here we show that PCNA and p21 are common components of a wide variety of cyclin/cyclin-dependent kinase complexes in nontransformed cells. These include kinase complexes containing cyclin A, cyclin B, and cyclin D, associated either with CDC2, CDK2, CDK4, or CDK5. We show that PCNA and p21 form separate quatemary complex with each cyclin/CDK and that these quatemary complexes contain a substantial, if not major, fraction of the cell cycle kinases in asynchronously growing cells. These results suggest that PCNA and p21 may perform a common function for all these kinases.
INTRODUCTION
It is well established that the eukaryotic cell cycle is regulated by cyclin-dependent kinases (CDKs) (reviewed by Draetta, 1990; Hunter and Pines, 1991) . Each CDK requires the association of a cyclin that serves as a positive regulatory subunit for the kinase activity. In both budding and fission yeasts, a single catalytic subunit, p34cDc /cDc28, is required for both the G1/S and G2/M transitions through association with either Gl cyclins (CLN-type) or mitotic cyclins (B-type) (Booher and Beach, 1987; Hadwiger et al., 1989; Wittenberg et al., 1990; Bueno et al., 1991; Ghiara et al., 1991; Surana et al., 1991) . In vertebrates, whereas p34CDC2 plays an essential role in mitosis (Riabowol et al., 1989 ; reviewed by Draetta, 1990) , the function of p34CDC2 in Gl and S phases appears to be mediated not by a single kinase but by a family of CDC2-related proteins. Several of these putative kinases have been isolated from human and other vertebrates using methods that identify very closely related proteins (Paris et al., 1991; Meyerson et al., 1992; Xiong et al., 1992b) . Although the functions of most of these kinases in the cell cycle remain unknown, substantial evidence suggests that some of the CDC2-related kinases are involved in the regulation of the Gl and S phases in the cell cycle (Fang and Newport, 1991; Tsai et al., 1991 Elledge et al., 1992; Pagano et al., 1992a,b; Rosenblatt et al., 1992; Xiong et al., 1992b) .
To understand the function of the CDKs, much effort has been directed toward identifying the cyclins with which each catalytic subunit associates. At least two human B-type cyclins, cyclin Bi and B2, associate with p34CDC2 and function in mitosis (Draetta and Beach, 1988; Draetta et al., 1989 ; reviewed by Draetta, 1990; Hunter and Pines, 1991) . In addition to cyclin B, cyclin A has been shown to complex with p34 DC2 in higher eukaryotic cells and may also perform a function during mitosis in both embryonic and somatic cells Lehner and O'Farrell, 1990; Minshull et al., 1990; Devault et al., 1992; Pagano et al., 1992b) . However, human cyclin A complexes predominantly with p33CDK2, a CDC2-related kinase catalytic subunit that functions during S-phase (Girard et al., 1991; Paris et al., 1991; Tsai et al., 1991; Pagano et al., 1992b) .
Three putative human Gl cyclins, cyclin C, cyclin Dl, and cyclin E, have been isolated by virtue of their ability to rescue a budding yeast strain that lacks Gl cyclin (CLN) function (Koff et al., 1991; Lew et al., 1991; Xiong et al., 1991) . Cyclin Dl, also called PRAD1, was also isolated as a putative oncogene located on q13 of chromosome 11, the BCL1 rearrangement locus in certain lymphomas, leukemias, and breast cancers (Motokura et al., 1991; Withers et al., 1991) . Mouse homologue of human cyclin Dl was identified independently as a gene whose expression is stimulated by colony-stimulating factor 1 in macrophage cells (Mat-sushime et al., 1991) . Three D-type cyclins, cyclins Dl-D3, have been identified in both mouse and human cells (Matsushime et al., 1991; Inaba et al., 1992; Xiong et al., 1992a) . It was recently found that three CDC2-related kinases, CDK2, CDK4 (also called PSK-J3), and CDK5 (also called PSSALRE), form in vivo complexes with both cyclin Dl and cyclin D3 Xiong et al., 1992b) . The function of cyclin D with its associated multiple kinase subunits in the cell cycle has yet to be established.
One approach to study the function and regulation of cyclin/CDK kinases in the cell cycle is to analyze their associated proteins. Human cyclin A was initially identified as the p60 protein associated with the adenovirus ElA oncoprotein (Harlow et al., 1986; Giordano et al., 1989; Pines and Hunter, 1990) . The association between cyclin A and ElA was later shown to be mediated by pRblO7, a homologue of the retinoblastoma susceptibility gene product pRblO5 (Ewen et al., 1991 Faha et al., 1992) . The cyclin A/pRblO7 complex was also found to contain CDK2 and E2F (Mudryj et al., 1991; Cao et al., 1992; Devoto et al., 1992; Pagano et al., 1992a; Shirodkar et al., 1992) . E2F is an S-phase specific cellular transcription factor that is also required for transcription of the adenovirus E2 gene. Cyclin E has also been shown to complex with CDK2 and pRblO7/E2F (Koff et al., 1991; Dulic et al., 1992; Lees et al., 1992) . These studies suggest that cyclin A and cyclin E/CDK2 kinases may be involved in regulation of E2F activities during G1/S-phase.
Recently, we have shown that two proteins, p36 and p21, form complexes with cyclin D and its associated kinases in normal human fibroblasts (Xiong et al., 1992b) . The p36 protein was identified as the proliferating cell nuclear antigen (PCNA), a protein previously shown to be involved in both DNA replication and repair (Bravo et al., 1987; Prelich et al., 1987a,b; Prelich and Stillman, 1988; Toschi and Bravo, 1988; Shivji et al., 1992) . The identity of p21 is currently unknown. Here, we show that PCNA and p21 are common components of almost all known cell cycle kinase complexes in normal human fibroblasts. These kinase complexes include cyclin A, cyclin B, and cycin D associated with CDC2, CDK2, CDK4, and CDK5.
MATERIALS AND METHODS Cells
Human diploid cells of lung fibroblasts W138 and IMR-90, foreskin fibroblast Hs68, and fibroblast-like Detroit 551 were obtained from American Type Culture Collection (Rockville, MD). They were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and used between passages 16-23. HeLa, 293, CV1 cells were obtained from cell culture facilities at Cold Spring Harbor Laboratory (Cold Spring Harbor, NY) and cultured similarly.
Antibodies
Antibodies raised against the carboxy-terminal peptides of human CDC2, CDK2, CDK5, and the full-length cyclin Dl were described previously (Draetta and Beach, 1988; Xiong et al., 1992b) . For anti-CDK4 antibody production, a peptide CHSYLHKDEGNPE with the underlined region corresponding to the unique carboxy-terminal region of CDK4 (Hanks, 1987) , was synthesized. The peptide was coupled to keyhole limpet hemocyanin (Pierce, Rockford, IL), which was then used to immunize rabbits as described (Xioung et al., 1992b) . Anticyclin Bi monoclonal antibodies (mAbs) were obtained from Phar- mingen (San Diego, CA) (GNS-1 and GNS-11). The GNS-11 mAb was used in the immunoprecipitations shown in Figure 1B and Figure   7 , A and B. However, later we found that this antibody coimmunoprecipitates much less PCNA than the GNS-1 mAb, although both anti-cyclin B1 antibodies immunoprecipitate similar amounts of cyclin B1 (unpublished data). The GNS-1 antibody was used in the immunoprecipitation shown in Figure 3C . The anti-cyclin A polyclonal antibody was a gift from Dr. Antonio Giordano at Temple University, Philadelphia. The affinity purified anti-full length cyclin E antibody was provided by Dr. Konstantin Galaktionov at Cold Spring Harbor Laboratory.
Immunoprecipitation and Western Blotting
Metabolic labeling of cells with [315]-methionine and immunoprecipitation of labeled proteins were performed as described before (Xiong et al., 1992b) . Immunoprecipitation of unlabeled proteins and Western blotting were conducted as described (Xiong et al., 1992b) . For experiments shown in Figure 6 , log-phase growing W138 cells were lysed in ice-cold 0.5% NP40 lysis buffer (0.5% NP40, 150 mM NaCl, 50 mM tris(hydroxymethyl)aminomethane [Tris] , pH 7.4, 1 mM sodium vanadate, 50 mM NaF, 25 Mg/ml each of following protease inhibitors: aprotinin, leupeptin, soybean trypsin inhibitor, and 1 mM benzamidine). The cell lysate was centrifuged in microfuge at top speed for 5 min at 4°C. After removing the soluble (cytosolic) fraction, the insoluble (nuclear) fraction, which was pelleted at bottom, was resuspended in equal volume of lysis buffer and extracted with 0.6 M NaCl (final concentration) on ice for 1 h. The nuclear extract was cleared of insoluble material and immunoprecipitated with various anti-cyclin, anti-CDK, or anti-PCNA antibodies. The cytosolic fraction was similarly immunoprecipitated with various antibodies after adjusting to final 0.6 M NaCl. In another set, the nuclear fraction was adjusted with lysis buffer to the same volume as the cytosolic fraction. 2XSDS sample buffer (4% sodium dodecyl sulfate [SDS], 160 mM Tris, pH 6.8, 20% glycerol, 10% f-mercaptoethanol, and 0.02% bromophenol blue) was then added directly to the cytosolic and nuclear fractions and processed for loading of SDS-polyacrylamide gel electrophoresis (PAGE) without immunoprecipitation. The proteins from both immunoprecipitation and direct loading were detected by Western-blot as described above.
Partial Staphylococcus aureus V8 Protease Mapping
The partial V8 proteolytic mapping of p36/PCNA, p35/cyclin Dl and p21 from various immunoprecipitations and in vitro translation were performed as described before (Cleveland et al., 1977; Xiong et al., 1992b) .
Glycerol Gradient Sedimentation
Log-phase growing WI38 cells (60-70% confluency) were labeled with
[35S]-methionine (35S express, #cat: NE0072, New England Nuclear, Boston, MA) in 0.25 mCi/ml for 5 h as described (Xiong et al., 1992b) .
The cells were lysed in a minimal volume (usually 300 Al) of lysis buffer (0.5% NP40, 150 mM NaCl, 50 mM Tris, pH 7.4, 1 mM sodium vanadate, 50 mM NaF, 25 Mg/ml each of following protease inhibitors: aprotinin, leupeptin, soybean trypsin inhibitor, and 1 mM benzamidine). The lysates were cleared of nuclear fractions and loaded directly onto a 15-35% glycerol gradient (total 9.5 ml) in the lysis buffer. The gradient was ultra-centrifuged at 40 000 rpm in a SW41.Ti rotor (Beckman, Palo Alto, CA) at 4°C for 36 h. The molecular weight markers were centrifuged in a separate tube under the same conditions. RESULTS p36, p35, and p21 Associate with CDC2 Four mammalian CDKs, CDC2, CDK2, CDK4, and CDK5 have been shown to associate with cyclins Tsai et al., 1991; Xiong et al., 1992b) . In addition to cycins, mammalian homologues of yeast Sucl, p9CKShs1 and p9CKShs2, were shown to associate with CDC2 (Richardson et al., 1990) . Vertebrate CDC25 protein also associates with cyclin B, and this association stimulates the tyrosine phosphatase activity of CDC25 (Galaktionov and Beach, 1991; Jesus and Beach, 1992) . In an effort to identify potential regulatory proteins that associate with various CDKs, we compared the proteins immunoprecipitated by a panel of antibodies raised specifically against human CDC2, CDK2, CDK4, and CDK5 from [ 5S]-labeled W138 cell lysates ( Figure 1A ) after SDS-PAGE. WI38 human fibroblast cells were chosen in these experiments because it is a relatively normal human cell line. We have previously shown that anti-CDK5 antibody specifically immunoprecipitates p31CDK5 as well as proteins with Mr -36 (p36), 35 (p35), 33 (p33), and 21 (p21) kDa ( Figure 1A , lane 2). p36 has been identified as PCNA. p35 and p33 were shown to be cycin Dl and D3, respectively. The identity of p21 is unknown but is identical to the 21 kDa protein seen in anti-cyclin Dl immunoprecipitates ( Figure 1B , lane 3) (Xiong et al., 1992b) . p36/PCNA, p35/cyclin Dl, and p21 were also present in the anti-CDK2 and anti-CDK4 immunoprecipitations as characterized before (Xiong et al., 1992b) ( Figure 1A , lanes 5 and 6). When proteins in the anti-CDC2 immunoprecipitates were analyzed, polypeptides that correspond to p34CDc2 and possibly two mitotic cyclins, cyclin Bi and B2 were observed ( Figure 1A , lane 4). In addition, three other polypeptides, p36, p21, and, to a lesser extent, p35, were also present in the anti-CDC2 immunoprecipitates (Figure 1A, lane 4) . Because the electrophoretic mobilities of these three proteins correspond to those of the previously described p36/PCNA, p35/cyclin Dl, and p21 in the anti-CDK2, anti-CDK4, and anti-CDK5 immunoprecipitations ( Figure 1A , lanes 2, 5, and 6), we have investigated the molecular identities of these three CDC2-associated proteins.
CDC2-associated p35 Is Cyclin Dl To determine whether CDC2 indeed complexes with p35/cyclin Dl, immunoblot analysis was first conducted. When anti-cyclin Dl immunoprecipitates were immunoblotted with anti-CDC2 antibody, a 34-kDa protein that comigrated with p34CDC2, was detected ( Figure 2A, lanes 2 and 3) . Reciprocal immunoblotting using anti-cyclin Dl antibody also detected a 35-kDa protein in the anti-CDC2 immunoprecipitation that has the same electrophoretic mobility as cyclin Dl (unpublished data) . No polypeptides were detected when a control serum was used (Figure 2A, lane 1) . To conclusively determine that cyclin Dl is associated with CDC2, partial S. aureus V8 proteolytic mapping (Cleveland et al., 1977) was also performed. The V8 proteolytic pattern of p35 from anti-CDC2 immunoprecipitation was compared with that of cyclin Dl obtained from either anticyclin Dl immunoprecipitation from labeled cell lysate or from in vitro translation. These experiments confirmed that p35 in the anti-CDC2 immunoprecipitation is indeed cyclin Dl ( Figure 2B , compare lanes 1-3 and 4-6 with lanes 7-9). These data indicate that cyclin Dl also associates with p34CDc2 in vivo. Thus cyclin D appears to be capable of complexing with various members of CDK family including CDC2, CDK2, CDK4, and CDK5, suggesting cycin D may have multiple functions in the cell cycle. However, the cyclin D1/CDC2 complex appeared to be much less abundant than the complexes formed between cyclin Dl and other kinase catalytic subunits in an asynchronous cell population ( Figure 1A , lanes 2, and 4-6).
p36 and p21 in Anti-Cyclin A and Cyclin Bi Complexes Because p36/PCNA has been shown to associate with CDK2, CDK4, and CDK5 ( Figure 1A , lanes 2, 5, and 6) (Xiong et al., 1992b) , the presence of a 36-kDa protein in the anti-CDC2 immunoprecipitation raised the possibility that it might be PCNA. Although we show that cycin D associates with CDC2, the prominence of p36 in the anti-CDC2 immunoprecipitation could hardly be attributed to the existence of a much less abundant cyclin D1/CDC2 complex ( Figure 1A , lane 4). Because p34CDC2 iS mostly associated with cyclin B and cyclin A (Draetta and Beach, 1988; Draetta et al., 1989) Figure   1B , lane 3) (Xiong et al., 1992b Figure 3 , A and B, the proteolytic patterns of the p36 from anti-CDC2, anti-cyclin A, and anticyclin Bi immunoprecipitates are identical to those of PCNA, indicating that PCNA indeed associates with CDC2, cyclin A, and cyclin Bi. Immunoblot analysis using anti-PCNA antibody also confirmed that substantial amount of PCNA was associated with cyclin Bi ( Figure 3C ). We have also analyzed the proteins that associate with cyclin E. It appeared that proteins that comigrated with p36/PCNA and p21 were also present in anti-cyclin E immunoprecipitation. However, because of the low abundance of cyclin E, we have not been able to confirm the identity of these cyclin E-associated proteins. PCNA has been shown to associate with cycin D and its associated CDK2, CDK4, and CDK5 (Xiong et al., 1992b ) ( Figure 1A , lanes 2, 5, and 6; Figure 1B Figure  1A , lanes 2, 5, and 6; Figure 1B , lane 3). The electrophoretic mobility of 21-kDa proteins in the anti-CDC2, anti-cyclin A, and anti-cyclin B1 immunoprecipitations raised the possibility that they are the same p21 associated with cyclin D. To test that, the V8 partial proteolytic patterns of p21 from anti-CDC2, anti-cyclin A, and anti-cyclin Bi immunoprecipitates were compared with that of p21 from anti-cyclin Dl immunoprecipitation (Figure 4 , A-C). These experiments confirmed that the same p21 is present in anti-CDC2, anti-cyclin A, Bi, and Dl immunoprecipitations (Figure 4 , A-C). These results indicate that p21, in addition to PCNA, is another general component of various cyclin/CDK complexes.
PCNA and p21 Associate with the Complexed Cyclin/CDK kinases In many cases the intensity of the labeled PCNA band roughly correlates with that of p21 in the immunoprecipitation (Figure 1 and Figure 7) . Furthermore, in transformed cells such as 293 cells, both p21 and PCNA are absent from the anti-cyclin or anti-CDK immunoprecipitations (Xiong et al., 1992b) . Previously we have shown that anti-PCNA antibody can also immunoprecipitate p21 in addition to cyclin Dl and its associated CDKs (Xiong et al., 1992b Figure 5C ). Similar results were obtained from analysis of other -30K
PCNA/p21/cyclin/CDK complexes (e.g. Figure 5A ). These data suggest the existence of quatemary cell cycle kinase complexes that consist of PCNA/p21/cycin/ -1A.4K
CDK, and they may represent a substantial, if not major, complexes. In these cases, complexes composed mostly of p21/cyclin/CDK seemed also to exist ( Figure 5A ).
These results suggest that p21 may bind to cyclin/CDK 30K complexes independent of PCNA. -30K
Because we have analyzed the quatemary complexes in the soluble fraction of cell lysates, it is possible that -18.4K
we might be examining a small fraction of soluble PCNA and cyclin/CDK complex released from nuclei during the lysate preparation. To determine the fractions of PCNA, cyclins and CDKs in the cell lysate, we have compared the presence of these proteins in the cytosolic (the soluble) and the nuclear (the insoluble) fractions _200K under our assay conditions. Our data suggested that >90% of PCNA, cyclins, and CDKs are present in the soluble fraction (Figure 6 ). The amount of cyclin A and -97K CDK2 in the insoluble fraction seemed to be slightly higher than other cyclins and CDK proteins. We do not -68K know the fraction of p21 in the cytosol, because there L5". antisera and analyzed by SDS-PAGE as described in Figure 1 . munological methods. We have established the existence of a protein complex between cyclin Dl and human p34 C2, a cell cycle kinase catalytic subunit that acts at mitosis in vertebrates (reviewed by Draetta, 1990) . However, in an asynchronous cell population, the cyclin D1/CDC2 complex seems to be relatively much lower in abundance than other cyclin D1/CDK complexes ( Figure 1A and Figure 7, A (Hanks, 1987; Matsushime et al., 1992; Meyerson et al., 1992; Xiong et al., 1992b (Xiong et al., 1992b ). In the current study, the same p36/PCNA and p21 were also found to associate with other major classes of cell cycle kinase complexes including cyclin B/CDC2 and cyclin A/CDK2. These data indicate that PCNA and p21 are common protein components that form various quaternary complexes with a broad spectrum of cyclin/CDK complexes including cyclin A, cyclin Bi, cyclin Dl or D3 associated with CDC2, CDK2, CDK4, and CDK5. From these experiments, we expect that PCNA and p21 may also form quatemary complexes with other known or unknown cyclins or other closely-related members of CDK family (Koff, 1991; Lew et al., 1991; Meyerson et al., 1992) . In asynchronously growing cells, these quatemary complexes seem to represent a substantial, if not major, population of the cyclin/CDK complexes ( Figure 5 , B and C). Furthermore, the various complexes seem also to exist independently from each other, because there was no detectable p35/ cyclin Dl in the anti-cyclin A or anti-cyclin Bi immunoprecipitations ( Figure 1B) . However, we cannot rule out the possibility that these quaternary complexes interact with each other or associate with other proteins in vivo as a part of larger multi-protein complexes.
PCNA has been shown to be an accessory protein for DNA polymerase 6 and is required for DNA replication and repair (Bravo et al., 1987; Prelich et al., 1987a,b; Prelich and Stillman, 1988; Toschi and Bravo, 1988; Bauer and Burgers, 1990; Shivji et al., 1992; Waseem et al., 1992 In this regard, PCNA or p21 may mediate the phosphorylation process of some of the replication factors during S-phase or DNA repair. However, there are indications suggesting that PCNA is not simply a replication factor. Although the rate of synthesis of PCNA increases during S-phase, the total PCNA protein level appears to stay relative constant throughout the cell cycle (Wold et al., 1988; Morris and Mathews, 1989) . Our preliminary data show that there is a substantial amount of cyclin Dl and PCNA present in serumstarved, quiescent cells. They form complexes even under these conditions. The association of PCNA with cyclin/CDK complexes during Gl phase of the cell cycle suggests PCNA may have possible Gl functions. The association of PCNA and p21 with cyclin B/CDC2
complexes also indicate that they may play a role in either the coupling of DNA replication to mitosis or have a function in G2. Recently, it has been shown that the over-expression of PCNA in fission yeast caused a G2 delay in either wild-type or a cdc2 mutant strain (cdc2-3w), which can prematurely enter mitosis even when DNA synthesis is inhibited (Waseem et al., 1992) . One possible explanation is that PCNA may serve as a negative regulator for the CDC2 kinase at the G2/M transition. PCNA may also play a role in the Gl checkpoint control. In nontransformed cells, UV irradiation or other DNA damage agents causes cells to arrest both in Gl and G2 (Kastan et al., 1992) . PCNA has been shown to rapidly concentrate at the sites of DNA damage even in quiescent cells (Toschi and Bravo, 1988) . Under such instances, PCNA could possibly affect the activities of its associated cell cycle kinases in G1 phase in a way similar to that of DNA replication during the S-phase of the cell cycle. The possibility that PCNA and p21 may be directly involved in the regulation of various cell cycle kinases by coupling to other biological processes remains to be established.
In our study, the quatemary complex of PCNA/p21/ cyclin/CDK is observed only in nontransformed human cells. In transformed cells such as HeLa or 293 cells, PCNA and p21 are absent from most of cyclin/CDK kinase complexes although the level of PCNA remains about the same as in nontransformed cells (Xiong et al., 1992b (Xiong et al., , 1993 ). It appears that transformation is also ac-companied by subunit rearrangement of the cell cycle kinase complexes (Xiong et al., 1993) . It remains to be established the functional differences in the cell cycle kinases between normal and transformed cells.
